Shanxi Kangbao Biological Product Co., Ltd.

This early-stage study tested the safety of a new HIV drug called LP-98, given as injections under the skin. It involved 40 people with HIV who had not yet started treatment. Researchers checked for side effects and measured how the drug moved through the body at different doses.

This study tested a new, long-acting injectable drug called Lipovirtide for people newly diagnosed with HIV who had not yet started treatment. The goal was to see if giving this injection once a week or once every two weeks, along with daily pills, could effectively control the v…